T. Rowe Price Associates’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$248K Buy
38,827
+27,027
+229% +$173K ﹤0.01% 2610
2025
Q1
$58K Hold
11,800
﹤0.01% 2905
2024
Q4
$113K Hold
11,800
﹤0.01% 2805
2024
Q3
$99K Buy
+11,800
New +$99K ﹤0.01% 2820
2024
Q2
Sell
-23,943
Closed -$61K 2951
2024
Q1
$61K Buy
23,943
+4,409
+23% +$11.2K ﹤0.01% 2850
2023
Q4
$47K Buy
19,534
+1,339
+7% +$3.22K ﹤0.01% 2812
2023
Q3
$62K Sell
18,195
-9,495
-34% -$32.4K ﹤0.01% 2743
2023
Q2
$204K Buy
27,690
+4,059
+17% +$29.9K ﹤0.01% 2519
2023
Q1
$245K Buy
23,631
+914
+4% +$9.48K ﹤0.01% 2438
2022
Q4
$268K Sell
22,717
-5,422
-19% -$64K ﹤0.01% 2409
2022
Q3
$592K Sell
28,139
-104,788
-79% -$2.2M ﹤0.01% 2040
2022
Q2
$4.13M Sell
132,927
-118,762
-47% -$3.69M ﹤0.01% 1445
2022
Q1
$10.3M Sell
251,689
-20,384
-7% -$837K ﹤0.01% 1359
2021
Q4
$11.8M Sell
272,073
-268,476
-50% -$11.7M ﹤0.01% 1385
2021
Q3
$27.1M Sell
540,549
-13,487
-2% -$675K ﹤0.01% 1216
2021
Q2
$34.9M Sell
554,036
-221,018
-29% -$13.9M ﹤0.01% 1157
2021
Q1
$72M Sell
775,054
-97,313
-11% -$9.04M 0.01% 870
2020
Q4
$78.2M Sell
872,367
-13,404
-2% -$1.2M 0.01% 810
2020
Q3
$91.5M Buy
885,771
+11,369
+1% +$1.17M 0.01% 680
2020
Q2
$69.1M Sell
874,402
-9,168
-1% -$725K 0.01% 741
2020
Q1
$51.1M Sell
883,570
-5,769
-0.6% -$334K 0.01% 776
2019
Q4
$48M Buy
889,339
+18,811
+2% +$1.01M 0.01% 922
2019
Q3
$45.5M Buy
870,528
+57,295
+7% +$3M 0.01% 905
2019
Q2
$39.3M Sell
813,233
-2,424
-0.3% -$117K 0.01% 963
2019
Q1
$41.2M Buy
815,657
+50,403
+7% +$2.55M 0.01% 948
2018
Q4
$45.4M Buy
765,254
+34,492
+5% +$2.04M 0.01% 865
2018
Q3
$48.1M Buy
730,762
+118,273
+19% +$7.79M 0.01% 926
2018
Q2
$30.9M Buy
612,489
+279,207
+84% +$14.1M ﹤0.01% 1059
2018
Q1
$17.5M Buy
333,282
+319,092
+2,249% +$16.8M ﹤0.01% 1224
2017
Q4
$659K Sell
14,190
-10
-0.1% -$464 ﹤0.01% 1962
2017
Q3
$574K Hold
14,200
﹤0.01% 2021
2017
Q2
$482K Buy
14,200
+10
+0.1% +$339 ﹤0.01% 2077
2017
Q1
$412K Buy
14,190
+10
+0.1% +$290 ﹤0.01% 2137
2016
Q4
$466K Buy
14,180
+4,200
+42% +$138K ﹤0.01% 2075
2016
Q3
$315K Buy
+9,980
New +$315K ﹤0.01% 2195
2013
Q4
Sell
-13,673
Closed -$260K 2493
2013
Q3
$260K Buy
+13,673
New +$260K ﹤0.01% 2165